Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus.

Jasenosky LD, Cadena C, Mire CE, Borisevich V, Haridas V, Ranjbar S, Nambu A, Bavari S, Soloveva V, Sadukhan S, Cassell GH, Geisbert TW, Hur S, Goldfeld AE.

iScience. 2019 Jul 24. pii: S2589-0042(19)30228-7. doi: 10.1016/j.isci.2019.07.003. [Epub ahead of print]

2.

A Spray-dried Combination of Capreomycin and CPZEN-45 for Inhaled Tuberculosis Therapy.

Pitner RA, Durham PG, Stewart IE, Reed SG, Cassell GH, Hickey AJ, Carter D.

J Pharm Sci. 2019 May 29. pii: S0022-3549(19)30356-9. doi: 10.1016/j.xphs.2019.05.024. [Epub ahead of print]

PMID:
31152746
3.

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.

Manson AL, Cohen KA, Abeel T, Desjardins CA, Armstrong DT, Barry CE 3rd, Brand J; TBResist Global Genome Consortium, Chapman SB, Cho SN, Gabrielian A, Gomez J, Jodals AM, Joloba M, Jureen P, Lee JS, Malinga L, Maiga M, Nordenberg D, Noroc E, Romancenco E, Salazar A, Ssengooba W, Velayati AA, Winglee K, Zalutskaya A, Via LE, Cassell GH, Dorman SE, Ellner J, Farnia P, Galagan JE, Rosenthal A, Crudu V, Homorodean D, Hsueh PR, Narayanan S, Pym AS, Skrahina A, Swaminathan S, Van der Walt M, Alland D, Bishai WR, Cohen T, Hoffner S, Birren BW, Earl AM.

Nat Genet. 2017 Mar;49(3):395-402. doi: 10.1038/ng.3767. Epub 2017 Jan 16.

4.

Populations of latent Mycobacterium tuberculosis lack a cell wall: Isolation, visualization, and whole-genome characterization.

Velayati AA, Abeel T, Shea T, Konstantinovich Zhavnerko G, Birren B, Cassell GH, Earl AM, Hoffner S, Farnia P.

Int J Mycobacteriol. 2016 Mar;5(1):66-73. doi: 10.1016/j.ijmyco.2015.12.001. Epub 2015 Dec 28.

5.

Shifting gears to control drug-resistant tuberculosis.

Berkelman RL, Cassell GH, Whitney EA, Keshavjee S.

Clin Infect Dis. 2014 Sep 15;59(6):908-10. doi: 10.1093/cid/ciu479. Epub 2014 Jun 18. No abstract available.

PMID:
24944229
6.

Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains.

Paralanov V, Lu J, Duffy LB, Crabb DM, Shrivastava S, Methé BA, Inman J, Yooseph S, Xiao L, Cassell GH, Waites KB, Glass JI.

BMC Microbiol. 2012 May 30;12:88. doi: 10.1186/1471-2180-12-88.

7.

Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence.

Farley JE, Ram M, Pan W, Waldman S, Cassell GH, Chaisson RE, Weyer K, Lancaster J, Van der Walt M.

PLoS One. 2011;6(7):e20436. doi: 10.1371/journal.pone.0020436. Epub 2011 Jul 22.

8.

Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes.

Xiao L, Paralanov V, Glass JI, Duffy LB, Robertson JA, Cassell GH, Chen Y, Waites KB.

J Clin Microbiol. 2011 Aug;49(8):2818-26. doi: 10.1128/JCM.00637-11. Epub 2011 Jun 22.

9.

Detection and characterization of human Ureaplasma species and serovars by real-time PCR.

Xiao L, Glass JI, Paralanov V, Yooseph S, Cassell GH, Duffy LB, Waites KB.

J Clin Microbiol. 2010 Aug;48(8):2715-23. doi: 10.1128/JCM.01877-09. Epub 2010 Jun 16.

10.

Deficient immune response to Mycoplasma pneumoniae in childhood asthma.

Atkinson TP, Duffy LB, Pendley D, Dai Y, Cassell GH.

Allergy Asthma Proc. 2009 Mar-Apr;30(2):158-65. doi: 10.2500/aap.2009.30.3207.

PMID:
19463205
11.

Ureaplasma parvum or Mycoplasma hominis as sole pathogens cause chorioamnionitis, preterm delivery, and fetal pneumonia in rhesus macaques.

Novy MJ, Duffy L, Axthelm MK, Sadowsky DW, Witkin SS, Gravett MG, Cassell GH, Waites KB.

Reprod Sci. 2009 Jan;16(1):56-70. doi: 10.1177/1933719108325508. Epub 2009 Jan 2.

PMID:
19122105
12.

Grand challenges for psychiatric drug discovery: a perspective.

Brady LS, Giffin RB, Woodcock J, Cassell GH, Holmes EW.

Neuropsychopharmacology. 2008 Aug;33(9):2047. doi: 10.1038/npp.2008.54. No abstract available.

13.

Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever.

Hensley LE, Stevens EL, Yan SB, Geisbert JB, Macias WL, Larsen T, Daddario-DiCaprio KM, Cassell GH, Jahrling PB, Geisbert TW.

J Infect Dis. 2007 Nov 15;196 Suppl 2:S390-9.

PMID:
17940975
14.
15.

A role for the Mycoplasma pneumoniae adhesin P1 in interleukin (IL)-4 synthesis and release from rodent mast cells.

Hoek KL, Duffy LB, Cassell GH, Dai Y, Atkinson TP.

Microb Pathog. 2005 Oct;39(4):149-58.

PMID:
16169702
16.

Effects of antenatal colonization with ureaplasma urealyticum on pulmonary disease in the immature baboon.

Yoder BA, Coalson JJ, Winter VT, Siler-Khodr T, Duffy LB, Cassell GH.

Pediatr Res. 2003 Dec;54(6):797-807. Epub 2003 Aug 20.

PMID:
12930907
17.

Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin.

Kraft M, Cassell GH, Pak J, Martin RJ.

Chest. 2002 Jun;121(6):1782-8.

PMID:
12065339
18.

Lung pathology in premature infants with Ureaplasma urealyticum infection.

Viscardi RM, Manimtim WM, Sun CC, Duffy L, Cassell GH.

Pediatr Dev Pathol. 2002 Mar-Apr;5(2):141-50.

PMID:
11910508
19.

Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells.

Hoek KL, Cassell GH, Duffy LB, Atkinson TP.

J Allergy Clin Immunol. 2002 Mar;109(3):470-6.

PMID:
11897994
20.

Midtrimester vaginal Mycoplasma genitalium in women with subsequent spontaneous preterm birth.

Lu GC, Schwebke JR, Duffy LB, Cassell GH, Hauth JC, Andrews WW, Goldenberg RL.

Am J Obstet Gynecol. 2001 Jul;185(1):163-5.

PMID:
11483922
21.

A link between chronic asthma and chronic infection.

Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH.

J Allergy Clin Immunol. 2001 Apr;107(4):595-601.

PMID:
11295645
23.

The complete sequence of the mucosal pathogen Ureaplasma urealyticum.

Glass JI, Lefkowitz EJ, Glass JS, Heiner CR, Chen EY, Cassell GH.

Nature. 2000 Oct 12;407(6805):757-62.

PMID:
11048724
24.

Antibody responses after Sendai virus infection and their role in upper and lower respiratory tract disease in rats.

Liang SC, Simecka JW, Lindsey JR, Cassell GH, Davis JK.

Lab Anim Sci. 1999 Aug;49(4):385-94.

PMID:
10480643
25.

Mycoplasma penetrans bacteremia and primary antiphospholipid syndrome.

Yáñez A, Cedillo L, Neyrolles O, Alonso E, Prévost MC, Rojas J, Watson HL, Blanchard A, Cassell GH.

Emerg Infect Dis. 1999 Jan-Feb;5(1):164-7.

26.

Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.

Harris JA, Kolokathis A, Campbell M, Cassell GH, Hammerschlag MR.

Pediatr Infect Dis J. 1998 Oct;17(10):865-71.

PMID:
9802626
27.

Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma.

Kraft M, Cassell GH, Henson JE, Watson H, Williamson J, Marmion BP, Gaydos CA, Martin RJ.

Am J Respir Crit Care Med. 1998 Sep;158(3):998-1001. Erratum in: Am J Respir Crit Care Med 1998 Nov;158(5 Pt 1):1692.

PMID:
9731038
28.

Infectious causes of chronic inflammatory diseases and cancer.

Cassell GH.

Emerg Infect Dis. 1998 Jul-Sep;4(3):475-87.

29.

Roles of innate and adaptive immunity in respiratory mycoplasmosis.

Cartner SC, Lindsey JR, Gibbs-Erwin J, Cassell GH, Simecka JW.

Infect Immun. 1998 Aug;66(8):3485-91.

30.

Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease.

Gray GC, McPhate DC, Leinonen M, Cassell GH, Deperalta EP, Putnam SD, Karcher JA, Sawyer MH, Laurila A, Connor JD.

Clin Infect Dis. 1998 Jan;26(1):103-10.

PMID:
9455517
31.

Mycoplasma pulmonis inhibits electrogenic ion transport across murine tracheal epithelial cell monolayers.

Lambert LC, Trummell HQ, Singh A, Cassell GH, Bridges RJ.

Infect Immun. 1998 Jan;66(1):272-9.

32.

The role of scientific societies in addressing the threats of emerging infections: summary of roundtable discussion.

Cassell GH, Shimao T.

FEMS Immunol Med Microbiol. 1997 Aug;18(4):337-41. No abstract available.

33.

Emergent antibiotic resistance: health risks and economic impact.

Cassell GH.

FEMS Immunol Med Microbiol. 1997 Aug;18(4):271-4. Review. No abstract available.

34.

Mycoplasma pneumoniae: a frequent cause of pneumonia among U.S. Marines in southern California.

Gray GC, Duffy LB, Paver RJ, Putnam SD, Reynolds RJ, Cassell GH.

Mil Med. 1997 Aug;162(8):524-6.

PMID:
9271902
35.

Isolation of Mycoplasma hominis from a brain abscess.

Zheng X, Olson DA, Tully JG, Watson HL, Cassell GH, Gustafson DR, Svien KA, Smith TF.

J Clin Microbiol. 1997 Apr;35(4):992-4.

36.

Evaluation of the Etest for detection of tetracycline resistance in Mycoplasma hominis.

Waites KB, Crabb DM, Duffy LB, Cassell GH.

Diagn Microbiol Infect Dis. 1997 Apr;27(4):117-22.

PMID:
9154407
37.

Resistance to mycoplasmal lung disease in mice is a complex genetic trait.

Cartner SC, Simecka JW, Briles DE, Cassell GH, Lindsey JR.

Infect Immun. 1996 Dec;64(12):5326-31.

38.

Epitope mapping of the variable repetitive region with the MB antigen of Ureaplasma urealyticum.

Zheng X, Lau K, Frazier M, Cassell GH, Watson HL.

Clin Diagn Lab Immunol. 1996 Nov;3(6):774-8.

39.

Phylogenetic analysis of genes coding for 16S rRNA in mammalian ureaplasmas.

Harasawa R, Cassell GH.

Int J Syst Bacteriol. 1996 Jul;46(3):827-9.

PMID:
8782697
40.

Phylogenetic analysis of the 16S-23S rRNA intergenic spacer regions of the genus Ureaplasma.

Harasawa R, Lefkowitz EJ, Glass JI, Cassell GH.

J Vet Med Sci. 1996 Mar;58(3):191-5.

PMID:
8777224
41.
42.

Comparative severity of respiratory lesions of sialodacryoadenitis virus and Sendai virus infections in LEW and F344 rats.

Liang SC, Schoeb TR, Davis JK, Simecka JW, Cassell GH, Lindsey JR.

Vet Pathol. 1995 Nov;32(6):661-7.

PMID:
8592801
43.

Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response.

Cartner SC, Simecka JW, Lindsey JR, Cassell GH, Davis JK.

Infect Immun. 1995 Oct;63(10):4138-42.

44.
45.
46.

Association of post-cesarean delivery endometritis with colonization of the chorioamnion by Ureaplasma urealyticum.

Andrews WW, Shah SR, Goldenberg RL, Cliver SP, Hauth JC, Cassell GH.

Obstet Gynecol. 1995 Apr;85(4):509-14.

PMID:
7898825
47.

Isolation of Ureaplasma urealyticum from low birth weight infants.

Waites KB, Cassell GH, Duffy LB, Searcey KB.

J Pediatr. 1995 Mar;126(3):502; author reply 503-4. No abstract available.

PMID:
7869217
48.
49.

Concurrent outbreaks of pertussis and Mycoplasma pneumoniae infection: clinical and epidemiological characteristics of illnesses manifested by cough.

Davis SF, Sutter RW, Strebel PM, Orton C, Alexander V, Sanden GN, Cassell GH, Thacker WL, Cochi SL.

Clin Infect Dis. 1995 Mar;20(3):621-8.

PMID:
7756486
50.

Severe Mycoplasma disease--rare or underdiagnosed?

Cassell GH.

West J Med. 1995 Feb;162(2):172-5. No abstract available.

Supplemental Content

Loading ...
Support Center